uracil has been researched along with Cancer of Cervix in 26 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| " 5-Fluorouracil (5-FU) was effective against only one bladder cancer xenograft among 6 cancer xenografts tested." | 3.68 | [Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice]. ( Adachi, S; Akaza, H; Ishitsuka, H; Kanazawa, K; Miwa, M; Nitta, K; Sekiguchi, F; Tokita, H, 1991) |
| "The stage IIB-IIIB cervical cancer patients were randomized to have Tegafur-Uracil 225 mg/m(2)/day orally, 5 days a week and carboplatin 100 mg/m(2) IV over 30-60 min, weekly on day 1 concurrent with standard radiotherapy (Group A) or carboplatin alone concurrent with standard radiotherapy (Group B)." | 2.73 | A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: preliminary results. ( Kamnerdsupaphon, P; Khorprasert, C; Lertsanguansinchai, P; Lorvidhaya, V; Sangruchi, S; Sookpreedee, L; Suntornpong, N; Udompunturak, S; Veerasarn, V, 2007) |
| "Total 21 cases of cervical cancer were alloted randomly into 5'-DFUR group (daily dose 800 mg for 3 days) consisting of 11 patients and UFT group (daily dose 600 mg for 3 days) consisting of 10 patients, the unchanged substances (5'-DFUR in the 5'-DFUR group and tegafur concentrations in the UFT group) and 5-FU concentrations in serum and tissues were measured 6 hours after administration of the drugs." | 2.68 | [5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer]. ( Aida, I; Kasuga, Y; Ohwada, M; Sato, I; Suzuki, M; Tamura, T, 1995) |
| "Complete cases among them consisted of ovarian cancer 53 cases, uterine cervical cancer 86 cases and endometrial cancer 27 cases for a total of 166 cases." | 2.67 | [Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer]. ( Ibuki, Y; Igarashi, M; Ito, T; Kimura, H; Kosuge, T; Nagayama, M; Nogami, Y; Ohwada, N; Tsukagoshi, T; Yazaki, K, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (50.00) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakaguchi, I | 1 |
| Motohara, T | 1 |
| Saito, F | 1 |
| Takaishi, K | 1 |
| Fukumatsu, Y | 1 |
| Tohya, T | 1 |
| Shibata, S | 2 |
| Mimori, H | 1 |
| Tashiro, H | 1 |
| Katabuchi, H | 1 |
| Hattori, K | 1 |
| Kohchi, Y | 1 |
| Oikawa, N | 1 |
| Suda, H | 1 |
| Ura, M | 1 |
| Ishikawa, T | 1 |
| Miwa, M | 2 |
| Endoh, M | 1 |
| Eda, H | 1 |
| Tanimura, H | 1 |
| Kawashima, A | 1 |
| Horii, I | 1 |
| Ishitsuka, H | 2 |
| Shimma, N | 1 |
| CAVANAGH, D | 1 |
| MARTIN, DS | 1 |
| FERGUSON, JH | 1 |
| Veerasarn, V | 1 |
| Lorvidhaya, V | 1 |
| Kamnerdsupaphon, P | 1 |
| Suntornpong, N | 1 |
| Sangruchi, S | 1 |
| Lertsanguansinchai, P | 1 |
| Khorprasert, C | 1 |
| Sookpreedee, L | 1 |
| Udompunturak, S | 1 |
| Nagai, N | 2 |
| Mukai, K | 1 |
| Hirata, E | 1 |
| Jin, HH | 1 |
| Komatsu, M | 1 |
| Yunokawa, M | 1 |
| Hatae, M | 1 |
| Terahara, M | 1 |
| Hokanishi, H | 1 |
| Shimizu, A | 1 |
| Watanabe, S | 1 |
| Okuyama, D | 1 |
| Morioka, M | 1 |
| Yoda, A | 1 |
| Hoshino, K | 1 |
| Noguchi, Y | 1 |
| Takahashi, J | 1 |
| Notake, Y | 1 |
| Mitsuya, T | 1 |
| Suzuki, M | 3 |
| Aida, I | 1 |
| Ohwada, M | 2 |
| Sato, I | 1 |
| Tamura, T | 1 |
| Kasuga, Y | 1 |
| Kato, T | 1 |
| Yakushiji, M | 1 |
| Yamabe, T | 1 |
| Sugimori, H | 1 |
| Hidaki, T | 1 |
| Tsukamoto, N | 1 |
| Tazaki, T | 1 |
| Foksinski, M | 1 |
| Jaruga, P | 1 |
| Makarewicz, R | 1 |
| Olinski, R | 1 |
| Oshita, T | 1 |
| Shigemasa, K | 1 |
| Ohama, K | 1 |
| Takehara, K | 1 |
| Miyaoka, S | 1 |
| Shiota, M | 1 |
| Shirai, T | 1 |
| Tateyama, I | 1 |
| Ohwada, N | 1 |
| Nagayama, M | 1 |
| Kosuge, T | 1 |
| Tsukagoshi, T | 1 |
| Ibuki, Y | 1 |
| Igarashi, M | 1 |
| Yazaki, K | 1 |
| Ito, T | 1 |
| Nogami, Y | 1 |
| Kimura, H | 1 |
| Sekiguchi, F | 1 |
| Akaza, H | 1 |
| Tokita, H | 1 |
| Nitta, K | 1 |
| Adachi, S | 1 |
| Kanazawa, K | 1 |
| Sekiguchi, I | 2 |
| Tamada, T | 2 |
| Yabushita, H | 1 |
| Sawaguchi, K | 1 |
| Ueno, N | 1 |
| Hieda, S | 1 |
| Noguchi, M | 1 |
| Ishihara, M | 1 |
| Yamashita, K | 1 |
| Mitani, K | 1 |
| Morishita, Y | 1 |
| Inoue, K | 2 |
| Tanimura, T | 1 |
| Kaneshige, E | 2 |
| Fujiwara, K | 1 |
| Kobashi, Y | 1 |
| Kono, I | 1 |
| Sekiba, K | 2 |
| Nagai, S | 1 |
| Kamiya, H | 1 |
| Sato, K | 1 |
| Sakai, K | 1 |
| Noda, K | 1 |
| Teshima, K | 1 |
| Ikeda, M | 1 |
| Sugawa, T | 1 |
| Yamagata, S | 1 |
| Kohno, I | 1 |
| Sawaragi, I | 1 |
| Matsuoka, I | 1 |
| Inoue, S | 1 |
| Okumura, A | 1 |
| Tanaka, T | 1 |
| Onitsuka, Y | 1 |
| Yoshimura, T | 1 |
| Aiko, A | 1 |
| Ikuta, Y | 1 |
| Fukuma, K | 1 |
| Matsuura, K | 1 |
| Kawai, Y | 1 |
| Hirano, H | 1 |
| Taniguchi, H | 1 |
| Nishiyama, M | 1 |
| Yanase, H | 1 |
| Uematsu, A | 1 |
| Sugiyama, Y | 1 |
| Kosoĭ, GKh | 1 |
| Kholodnyi, MD | 1 |
| Mindlin, SS | 1 |
| Klunichenko, AM | 1 |
6 trials available for uracil and Cancer of Cervix
| Article | Year |
|---|---|
High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; | 2015 |
A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Female; Huma | 2007 |
[5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Fluoroura | 1995 |
[A multicenter cooperative study on supplementary chemotherapy of uterocervical cancer. The Kyushu UFT Study Group of Uterocervical Cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 1994 |
[Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; | 1992 |
[Phase II study of UFT in cancer of the uterine cervix].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1985 |
20 other studies available for uracil and Cancer of Cervix
| Article | Year |
|---|---|
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcino | 2003 |
CLOSED PELVIC PERFUSION IN ADVANCED GYNECOLOGIC CANCER.
Topics: Catheterization; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Female; Fluorouracil; F | 1965 |
UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.
Topics: 4-Butyrolactone; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocol | 2008 |
[Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female | 1984 |
[A case report: complete remission of stage IV uterine cervix carcinoma by immuno-chemotherapy with intraarterial infusion using implantable reservoir system].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined | 1995 |
Oxidative DNA base damage in cancerous tissues of patients undergoing brachytherapy.
Topics: Adenine; Brachytherapy; Cytosine; DNA Damage; DNA, Neoplasm; Female; Gas Chromatography-Mass Spectro | 1998 |
[A case of uterine cervical cancer in which UFT was an effective preoperative treatment].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration | 1999 |
[A patient with recurrent uterine cervical cancer successfully treated by combined modality therapy including local injection of anticancer agents based on CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubic | 2000 |
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; | 1991 |
Thymidylate synthase inhibition as a predictor of tumor sensitivity of fluorinated pyrimidines.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Mice; Middle A | 1990 |
[Experimental study on the effect of UFT with concomitant radiotherapy of uterine cervical cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell | 1989 |
[The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1989 |
[5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch | 1986 |
[In vitro effects of 5-FU on gynecologic malignant tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Line; Cells, Cultured; Colony-Fo | 1986 |
[UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrium; Female; Genital Neoplasms, Female; Huma | 1985 |
[A study on plasma and tissue 5-FU concentrations in patients with cervical cancer treated with UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Tegafur; Uracil; Uteri | 1985 |
[Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cervix Ute | 1985 |
[On the effect of methyluracil and Pentoxyl on induction of cancer of the uterine cervix and vagina in mice].
Topics: Animals; Benz(a)Anthracenes; Colchicine; Female; Glycols; Mice; Neoplasms, Experimental; Thiotepa; U | 1968 |
[The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Female; Hematologic Disease | 1969 |
[The use of pentoxyl in radium therapy of malignant neoplasms of female genitalia].
Topics: Adult; Female; Humans; Middle Aged; Radium; Rectal Neoplasms; Uracil; Uterine Cervical Neoplasms; Ut | 1966 |